A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro. (Q54657092)

2 June 2018

title

A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro. (English)

1 reference

2 June 2018

author name string

Hoai Thu Thi Tran

1

1 reference

2 June 2018

Yasuhiro Takeshima

2

1 reference

2 June 2018

Agus Surono

3

1 reference

2 June 2018

Mariko Yagi

4

1 reference

2 June 2018

Hiroko Wada

5

1 reference

2 June 2018

Masafumi Matsuo

6

1 reference

2 June 2018

publication date

1 July 2005

1 reference

2 June 2018

Molecular Genetics and Metabolism

published in

1 reference

2 June 2018

volume

85

1 reference

2 June 2018

issue

3

1 reference

2 June 2018

page(s)

213-219

1 reference

2 June 2018

Construction of a novel database containing aberrant splicing mutations of mammalian genes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Activation of a cryptic 5' splice site by U1 snRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Comparative analysis detects dependencies among the 5' splice-site positions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Transcriptional activation of the non-muscle, full-length dystrophin isoforms in Duchenne muscular dystrophy skeletal muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Heterogous dystrophin mRNA produced by a novel splice acceptor site mutation in intermediate dystrophinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Novel nonsense mutation (C-->A nt 10512) in exon 72 of dystrophin gene leading to exon skipping in a patient with a mild dystrophinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Advances in Duchenne muscular dystrophy gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

Chimeric RNA and 2'-O, 4'-C-ethylene-bridged nucleic acids have stronger activity than phosphorothioate oligodeoxynucleotides in induction of exon 19 skipping in dystrophin mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.03.006

10.1016/J.YMGME.2005.03.006

7 January 2021

Identifiers

DOI

1 reference

2 June 2018

release_dzpauxjbhjdh5fz55u6bcy3yiq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dzpauxjbhjdh5fz55u6bcy3yiq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

2 June 2018